1.New eudesmane sesquiterpenoids from Atractylodis Macrocephalae Rhizoma and their inhibitory activities against SREBPs.
Rui-Zhu XU ; Xuan ZHAO ; Yue-Yue DU ; Meng-Sha XU ; Xin-Guang LIU ; Zhi-Shen XIE ; Song GAO ; Jiang-Yan XU ; Pan WANG
China Journal of Chinese Materia Medica 2022;47(2):428-432
Three sesquiterpenoids were isolated and purified from the 95% ethanol extract of Atractylodis Macrocephalae Rhizoma by column chromatography on silica gel, Sephadex LH-20, ODS, and high-performance liquid chromatography(HPLC). Their chemical structures were identified on the basis of spectroscopic analysis and physiochemical properties as(7Z)-8β,13-diacetoxy-eudesma-4(15),7(11)-diene(1), 7-oxo-7,8-secoeudesma-4(15),11-dien-8-oic acid(2), and guai-10(14)-en-11-ol(3). Compounds 1 and 2 are new compounds and compound 3 was obtained from Compositae family for the first time. Compounds 1, 2, and 3 showed weak inhibitory activities against sterol regulatory element-binding proteins(SREBPs).
Atractylodes/chemistry*
;
Drugs, Chinese Herbal/chemistry*
;
Rhizome/chemistry*
;
Sesquiterpenes, Eudesmane/pharmacology*
;
Sterol Regulatory Element Binding Proteins/antagonists & inhibitors*
2.Sterol-independent repression of low density lipoprotein receptor promoter by peroxisome proliferator activated receptor gamma coactivator-1alpha (PGC-1alpha).
Jae Hoon JEONG ; Sehyung CHO ; Youngmi KIM PAK
Experimental & Molecular Medicine 2009;41(6):406-416
Peroxisome proliferator activated receptor (PPAR) gamma coactivator-1alpha (PGC-1alpha) may be implicated in cholesterol metabolism since PGC-1alpha co-activates estrogen receptor alpha (ERalpha) transactivity and estrogen/ERalpha induces the transcription of LDL receptor (LDLR). Here, we show that overexpression of PGC-1alpha in HepG2 cells represses the gene expression of LDLR and does not affect the ERalpha-induced LDLR expression. PGC-1alpha suppressed the LDLR promoter-luciferase (pLR1563-luc) activity regardless of cholesterol or functional sterol-regulatory element-1. Serial deletions of the LDLR promoter revealed that the inhibition by PGC-1alpha required the LDLR promoter regions between -650 bp and -974 bp. Phosphorylation of PGC-1alpha may not affect the suppression of LDLR expression because treatment of SB202190, a p38 MAP kinase inhibitor, did not reverse the LDLR down-regulation by PGC-1alpha. This may be the first report showing the repressive function of PGC-1alpha on gene expression. PGC-1alpha might be a novel modulator of LDLR gene expression in a sterol-independent manner, and implicated in atherogenesis.
Base Sequence
;
Cell Line, Tumor
;
Cholesterol/metabolism
;
Estrogen Receptor alpha/metabolism
;
Gene Expression Regulation
;
Heat-Shock Proteins/*genetics/*metabolism
;
Humans
;
Molecular Sequence Data
;
Promoter Regions, Genetic
;
RNA, Messenger/genetics
;
Receptors, LDL/*genetics/*metabolism
;
Sterol Regulatory Element Binding Protein 2/metabolism
;
Transcription Factors/*genetics/*metabolism
;
p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors